| - GRCh37:
- Chr1:55472864
- GRCh38:
- Chr1:55007191
| BSND | A156D | Bartter disease type 4A, not specified | Uncertain significance (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472911
- GRCh38:
- Chr1:55007238
| BSND | E172K | Bartter disease type 4A, not provided | Uncertain significance (May 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474008
- GRCh38:
- Chr1:55008335
| BSND | P224T | Bartter disease type 4A, not provided | Uncertain significance (Jul 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474075
- GRCh38:
- Chr1:55008402
| BSND | A246V | not provided, Bartter disease type 4A | Uncertain significance (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474011
- GRCh38:
- Chr1:55008338
| BSND | Q225* | not specified, not provided, Bartter disease type 4A
| Uncertain significance (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464956
- GRCh38:
- Chr1:54999283
| BSND | V33L | Bartter syndrome, Bartter disease type 4A | Pathogenic/Likely pathogenic (Feb 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474206
- GRCh38:
- Chr1:55008533
| BSND | K290E | not provided, Bartter disease type 4A | Uncertain significance (Jul 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474101
- GRCh38:
- Chr1:55008428
| BSND | E255Q | Bartter disease type 4A, not provided | Uncertain significance (Feb 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464606-55482845
| BSND | | Bartter disease type 4A | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr1:55472898
- GRCh38:
- Chr1:55007225
| BSND | | not provided, Bartter disease type 4A | Likely benign (Jan 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474169
- GRCh38:
- Chr1:55008496
| BSND | | not provided, Bartter disease type 4A | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472808
- GRCh38:
- Chr1:55007135
| BSND | | Bartter disease type 4A, not provided | Likely benign (Apr 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472685
- GRCh38:
- Chr1:55007012
| BSND | | not provided, Bartter disease type 4A | Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472943
- GRCh38:
- Chr1:55007270
| BSND | | not provided, Bartter disease type 4A | Likely benign (Sep 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464923
- GRCh38:
- Chr1:54999250
| BSND | G22S | Bartter disease type 4A | Uncertain significance (Feb 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464923
- GRCh38:
- Chr1:54999250
| BSND | G22R | Bartter disease type 4A | Uncertain significance (Feb 6, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr1:55472684
- GRCh38:
- Chr1:55007011
| BSND | P96L | Bartter disease type 4A, not specified | Uncertain significance (Feb 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472691
- GRCh38:
- Chr1:55007018
| BSND | | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55470778
- GRCh38:
- Chr1:55005105
| BSND | | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55474357
- GRCh38:
- Chr1:55008684
| BSND | | Bartter disease type 4A | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55474316
- GRCh38:
- Chr1:55008643
| BSND | | Bartter disease type 4A | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55474307
- GRCh38:
- Chr1:55008634
| BSND | | Bartter disease type 4A | Uncertain significance (Mar 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55474096
- GRCh38:
- Chr1:55008423
| BSND | P253L | Bartter disease type 4A | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55473973
- GRCh38:
- Chr1:55008300
| BSND | N212S | not provided, Bartter disease type 4A | Uncertain significance (Dec 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472790
- GRCh38:
- Chr1:55007117
| BSND | L131F | not provided, Bartter disease type 4A, not specified
| Uncertain significance (Aug 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472703
- GRCh38:
- Chr1:55007030
| BSND | W102C | Bartter disease type 4A | Uncertain significance (Apr 20, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55470790
- GRCh38:
- Chr1:55005117
| BSND | | Bartter disease type 4A, not provided | Likely pathogenic (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472679
- GRCh38:
- Chr1:55007006
| BSND | | not provided, Bartter disease type 4A | Likely benign (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464868
- GRCh38:
- Chr1:54999195
| BSND | | not provided, Bartter disease type 4A | Likely benign (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472944
- GRCh38:
- Chr1:55007271
| BSND | G183S | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Oct 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55472955
- GRCh38:
- Chr1:55007282
| BSND | | not provided, Bartter disease type 4A | Likely benign (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464869
- GRCh38:
- Chr1:54999196
| BSND | E4K | not provided, not specified, Bartter disease type 4A
| Uncertain significance (Feb 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55470742
- GRCh38:
- Chr1:55005069
| BSND | | not provided, not specified, Bartter disease type 4A
| Likely benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464911
- GRCh38:
- Chr1:54999238
| BSND | L18V | Bartter disease type 4A | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr1:55472799
- GRCh38:
- Chr1:55007126
| BSND | E135fs | Bartter disease type 4A | Uncertain significance (Oct 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55470779
- GRCh38:
- Chr1:55005106
| BSND | E88* | Bartter disease type 4A, not provided | Pathogenic (Jul 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472847
- GRCh38:
- Chr1:55007174
| BSND | P151fs | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Sep 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55474108
- GRCh38:
- Chr1:55008435
| BSND | Q257R | not specified, Bartter disease type 4A, not provided
| Uncertain significance (Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474148
- GRCh38:
- Chr1:55008475
| BSND | | not specified, not provided, Bartter disease type 4A
| Likely benign (Aug 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474197
- GRCh38:
- Chr1:55008524
| BSND | E287* | not specified, Inborn genetic diseases, not provided, Bartter disease type 4A | Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474395
- GRCh38:
- Chr1:55008722
| BSND | | not provided, Bartter disease type 4A | Benign (Jun 16, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474325
- GRCh38:
- Chr1:55008652
| BSND | | not provided, Bartter disease type 4A | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474051
- GRCh38:
- Chr1:55008378
| BSND | F238Y | Bartter disease type 4A | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55474034
- GRCh38:
- Chr1:55008361
| BSND | | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55473942
- GRCh38:
- Chr1:55008269
| BSND | D202N | Bartter disease type 4A | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55470733
- GRCh38:
- Chr1:55005060
| BSND | | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Oct 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55464835
- GRCh38:
- Chr1:54999162
| BSND | | not specified, Bartter disease type 4A | Benign/Likely benign (Jan 12, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464826
- GRCh38:
- Chr1:54999153
| BSND | | Bartter disease type 4A | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55464790
- GRCh38:
- Chr1:54999117
| BSND | | not provided, Bartter disease type 4A | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464743
- GRCh38:
- Chr1:54999070
| BSND | | not provided, Bartter disease type 4A | Benign (Jul 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464704
- GRCh38:
- Chr1:54999031
| BSND | | Bartter disease type 4A | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55464685
- GRCh38:
- Chr1:54999012
| BSND | | Bartter disease type 4A | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55464619
- GRCh38:
- Chr1:54998946
| BSND | | not provided, Bartter disease type 4A | Benign (Nov 10, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464875
- GRCh38:
- Chr1:54999202
| BSND | T6A | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55472879
- GRCh38:
- Chr1:55007206
| BSND | A161V | Bartter disease type 4A, not specified | Uncertain significance (Aug 23, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472706
- GRCh38:
- Chr1:55007033
| BSND | E103D | Inborn genetic diseases, not specified, Bartter disease type 4A, not provided | Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55470700
- GRCh38:
- Chr1:55005027
| BSND | | not specified, Bartter disease type 4A, not provided
| Likely benign (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464961
- GRCh38:
- Chr1:54999288
| BSND | | not specified, not provided, Bartter disease type 4A
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55473935
- GRCh38:
- Chr1:55008262
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55472856
- GRCh38:
- Chr1:55007183
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign/Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474231
- GRCh38:
- Chr1:55008558
| BSND | G298E | not provided, Bartter disease type 4A | Conflicting interpretations of pathogenicity (Nov 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55472854
- GRCh38:
- Chr1:55007181
| BSND | D153N | Inborn genetic diseases, not specified, Bartter disease type 4A, not provided | Conflicting interpretations of pathogenicity (Feb 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55474210
- GRCh38:
- Chr1:55008537
| BSND | E291G | not specified, not provided, Bartter disease type 4A
| Uncertain significance (May 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474262
- GRCh38:
- Chr1:55008589
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55474255
- GRCh38:
- Chr1:55008582
| BSND | L306P | not specified, not provided, Bartter disease type 4A
| Conflicting interpretations of pathogenicity (Dec 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55464922
- GRCh38:
- Chr1:54999249
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55470706
- GRCh38:
- Chr1:55005033
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign/Likely benign (Jan 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55465051
- GRCh38:
- Chr1:54999378
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign/Likely benign (Sep 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55465047
- GRCh38:
- Chr1:54999374
| BSND | | not specified, not provided, Bartter disease type 4A
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464986
- GRCh38:
- Chr1:54999313
| BSND | V43I | not specified, not provided, Bartter disease type 4A
| Benign/Likely benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464869
- GRCh38:
- Chr1:54999196
| BSND | E4* | not provided, Bartter disease type 4A, Hearing impairment
| Pathogenic (Apr 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464894
- GRCh38:
- Chr1:54999221
| BSND | I12T | Bartter syndrome, not provided, Bartter disease type 4A
| Conflicting interpretations of pathogenicity (Aug 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:55464998
- GRCh38:
- Chr1:54999325
| BSND | G47R | not provided, Bartter disease type 4A | Pathogenic (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464882
- GRCh38:
- Chr1:54999209
| BSND | R8L | Bartter disease type 4A | Pathogenic (Nov 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr1:55464887
- GRCh38:
- Chr1:54999214
| BSND | G10S | Bartter syndrome | Pathogenic (Jun 27, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:55464862
- GRCh38:
- Chr1:54999189
| BSND | M1I | not provided, Bartter disease type 4A | Pathogenic/Likely pathogenic (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55471779-55474873
- GRCh38:
- Chr1:55006106-55009200
| BSND | | Bartter disease type 4A | Pathogenic (Nov 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr1:55465016-55465056
- GRCh38:
- Chr1:54999343-54999383
| BSND | | Bartter disease type 4A | Pathogenic (Nov 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr1:55464881
- GRCh38:
- Chr1:54999208
| BSND | R8W | Bartter syndrome, not provided | Pathogenic/Likely pathogenic (Nov 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:55464860
- GRCh38:
- Chr1:54999187
| BSND | M1L | not provided, Bartter disease type 4A | Pathogenic (Sep 5, 2022) | criteria provided, multiple submitters, no conflicts |